First products for Ebola Virus Disease prequalified
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Diabetes mellitus is a public health challenge due to its high and increasing prevalence and associated morbidity and mortality that have health and economic impact on indi
A-31 Clinical Unit I at Accutest Research Laboratories (I) Pvt. Ltd has addressed the concerns highlighted in the Notice of Concern (NOC) by the WHO.
A first invitation to manufacturers of medicinal products for treatment of disorders caused by use of tobacco, to submit an Expression of Interest (EOI) for product evaluation
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO has added a fourth test to the l
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
A 1st Invitation for Expression of Interest (EOI) for treatment of multi-drug resistant bacterial infections has been published by the WHO Prequalification Unit - Medicines Assessment Team (PQT/MED
The recent ICH Harmonised Guideline M10 Bioanalytical Method Validation and Study Sample Analysis, adopted by ICH 24 May 2022, will be implemented by PQT/MED effective 1 May 2023